Detailed information for compound 980651

Basic information

Technical information
  • TDR Targets ID: 980651
  • Name: (7E,13E,17E)-18-bromooctadeca-7,13,17-trien-5 ,15-diynoic acid
  • MW: 349.262 | Formula: C18H21BrO2
  • H donors: 1 H acceptors: 2 LogP: 5.28 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: Br/C=C/C#C/C=C/CCCC/C=C/C#CCCCC(=O)O
  • InChi: 1S/C18H21BrO2/c19-17-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18(20)21/h4,6-7,9,15,17H,1-3,5,12,14,16H2,(H,20,21)/b6-4+,9-7+,17-15+
  • InChiKey: XQBBTNXASWDRIQ-XEFVWHOUSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Human immunodeficiency virus 1 Protease Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni intracisternal A-particle retropepsin (A02 family) Get druggable targets OG5_131408 All targets in OG5_131408

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Entamoeba histolytica retroviral aspartyl protease domain-containing protein Protease   99 aa 102 aa 32.4 %
Entamoeba histolytica retroviral aspartyl protease domain-containing protein Protease   99 aa 102 aa 32.4 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis thymidine phosphorylase 0.2959 1 0.5
Mycobacterium ulcerans thymidine phosphorylase 0.2959 1 1
Schistosoma mansoni intracisternal A-particle retropepsin (A02 family) 0.1528 0.3262 0.5
Mycobacterium tuberculosis Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) 0.2959 1 1
Mycobacterium leprae Probable anthranilate phosphoribosyltransferase TrpD 0.0835 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) Inhibition of rat ATP citrate lyase at 100 ug/ml ChEMBL. 1431940
IC50 (binding) = 10 uM Inhibition of HIV1 protease-mediated proteolysis of rabbit muscle lactate dehydrogenase by spectrophotometry ChEMBL. 1431940

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.